Altimmune’s (ALT) Market Perform Rating Reaffirmed at William Blair
William Blair reaffirmed their market perform rating on shares of Altimmune (NASDAQ:ALT – Free Report) in a research report sent to investors on Friday morning,RTT News reports. Several other equities analysts have also commented on the stock. Stifel Nicolaus assumed coverage on shares of Altimmune in a research note on Wednesday, January 8th. They issued […]
William Blair reaffirmed their market perform rating on shares of Altimmune (NASDAQ:ALT – Free Report) in a research report sent to investors on Friday morning,RTT News reports. Several other equities analysts have also commented on the stock. Stifel Nicolaus assumed coverage on shares of Altimmune in a research note on Wednesday, January 8th. They issued […]
